Lonza Group (FRA:LO3) FFO


FRA:LO3 Lonza Group Ltd FRA:LO3
72 GF Score
Price €579.60
GF Value €641.26
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Lonza Group FFO?

FFO (Funds from operations) only applies to REITs.

FRA:LO3
72GF Score
Lonza Group Ltd FRA:LO3
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Lonza Group (FRA:LO3) Overvalued in 2026?

Based on GuruFocus' analysis, Lonza Group stock appears to be undervalued. The current stock price of €579.60 is trading 9.6% below its estimated GF Value™ of €641.26. GuruFocus considers Lonza Group to be Modestly Undervalued.

Key valuation signals for FRA:LO3:

  • FFO:
  • GF Value™: €641.26 vs. price of €579.60 (9.6% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the FRA:LO3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Lonza Group Business Description

Address Muenchensteinerstrasse 38, Basel, CHE, 4002
Lonza Group is a contract development and manufacturing organization. It operates under four segments: small molecules, biologics, cell and gene, and capsules and health ingredients. Lonza derives its revenue primarily from long-term supply agreements with pharmaceutical customers. The company provides development and manufacturing services throughout the entire lifecycle of a product, from drug research to commercial supply. The majority of Lonza's customers are pharmaceutical and biotechnology companies, academic institutions, and government research organizations.
72GF Score

Get the complete analysis for FRA:LO3

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€579.60
Price
€641.26
GF Value